内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by McWherter Charles. Officer active across 2 companies, notably CymaBay Therapeutics, Inc.. Aggregated, 14 filings have been logged. Split: 2 buys · 0 sell. Total volume traded: €108k. Activity tracked since 18 May 2023. The latest transaction was filed on 21 January 2025 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to McWherter Charles
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报14 总计
25,000 股Common StockSEC:0001193125-25-259053:0
5,000 股@ US$6.5529.2% 占其流量Common StockSEC:0000950170-25-008461:0
10,000 股@ US$8.0070.8% 占其流量Common StockSEC:0000950170-24-134312:0
15,000 股Common StockSEC:0000950170-24-035470:0
31,938 股0Common StockSEC:0001062993-24-001432:0
2,250 股@ US$1.060.3% 占其流量Common StockSEC:0001062993-24-001164:0
4,828 股@ US$5.003.3% 占其流量Common StockSEC:0001062993-23-022793:0
11,342 股@ US$5.007.7% 占其流量Common StockSEC:0001062993-23-021139:0
21,743 股@ US$5.0015.2% 占其流量Common StockSEC:0001062993-23-019549:0
21,746 股@ US$5.0015.5% 占其流量Common StockSEC:0001062993-23-018280:0
21,746 股@ US$5.0014.7% 占其流量Common StockSEC:0001062993-23-016871:0
21,749 股@ US$5.0014.3% 占其流量Common StockSEC:0001062993-23-015088:0
21,749 股@ US$5.0014.7% 占其流量Common StockSEC:0001062993-23-013932:0
21,749 股@ US$5.0014.9% 占其流量Common StockSEC:0001062993-23-011865:0
About McWherter Charles
McWherter Charles is a declarant linked to CymaBay Therapeutics, Inc. as President of R&D and to 89bio, Inc. as Director. Across 14 filings, the sampled recent filings cover the period from 2023-05-19 to 2025-10-30, with EUR 107516 of buys and EUR 0 of sells, and the most frequent transaction nature is Option exercise.